According to the Swedish National Guidelines for Lung cancer [13] patients diagnosed with advanced or metastatic NSCLC should be tested for PD-(L)1 expression which corroborates with our findings where the majority of the study population had a record of a PD-(L)1 test. Here, CD274 is linked to non-small cell lung carcinoma.